World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
70
Citations
17334
World Ranking
1425
National Ranking
725

Shiv Srivastava publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Shiv Srivastava sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 383 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Shiv Srivastava D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Shiv Srivastava sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 70 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Shiv Srivastava is affiliated with the Uniformed Services University of the Health Sciences in the United States. Their research focuses extensively on prostate cancer, encompassing treatment, diagnosis, and prognosis through molecular and genetic approaches.

Their recent research output includes several papers published between 2020 and 2023, reflecting work in translational medicine and oncology-related specialties. Notable publications include:

  • Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer, 2020, Journal of Translational Medicine
  • A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry, 2020, European Urology
  • Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry, 2023, European Urology
  • A Urine Exosome Gene Expression Panel Distinguishes between Indolent and Aggressive Prostate Cancers at Biopsy, 2020, The Journal of Urology
  • African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer, 2020, International Journal of Cancer

Their frequent co-authors include:

  • György Petrovics
  • Albert Dobi
  • Inger L. Rosner
  • Isabell A. Sesterhenn
  • Jennifer Cullen

Shiv Srivastava has contributed multiple publications to key scientific venues, such as:

  • Cancer Epidemiology Biomarkers & Prevention
  • Brachytherapy
  • Cancer Research
  • European Urology
  • The Journal of Urology

Their main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with specific work in subfields such as:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Oncology
  • Radiology, Nuclear Medicine and Imaging

Shiv Srivastava's research covers a range of topics including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Molecular Biology Techniques and Applications
  • DNA Repair Mechanisms
  • Cancer Genomics and Diagnostics
  • Ferroptosis and cancer prognosis

Best Publications

  • Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

    Shiv Srivastava;Zhiqiang Zou;Kathleen Pirollo;William Blattner

  • Identification of Putative Stem Cell Markers, CD133 and CXCR4, in hTERT–Immortalized Primary Nonmalignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Lines and in Prostate Cancer Specimens

    Jun Miki;Bungo Furusato;Hongzhen Li;Yongpeng Gu

  • Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

    Yasuhito Yuasa;Shiv K. Srivastava;Claire Y. Dunn;Johng S. Rhim

  • PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer

    Vasantha Srikantan;Zhiqiang Zou;Gyorgy Petrovics;Linda Xu

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

    Markku Miettinen;Zeng-Feng Wang;Anders Paetau;Shyh-Han Tan

  • Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

    John J. Bauer;Isabell A. Sesterhenn;F.K. Mostofi;David G. McLeod

  • Elevated expression of PCGEM1 , a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients

    Gyorgy Petrovics;Wei Zhang;Mazen Makarem;Jesse P Street

  • A long noncoding RNA connects c-Myc to tumor metabolism

    Chiu Lien Hung;Ling Yu Wang;Yen Ling Yu;Hong Wu Chen

  • Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.

    Unknown

  • Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors

    Jun Fujita;Shiv K. Srivastava;Matthias H. Kraus;Johng S. Rhim

  • Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate Cancer

    Howard B. Heidenberg;Isabell A. Sesterhenn;Jaya P. Gaddipati;Christopher M. Weghorst

  • Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.

    Keiichiro Nakamura;Yutaka Yasunaga;Takehiko Segawa;Daejin Ko

  • A Novel Androgen-Regulated Gene, PMEPA1, Located on Chromosome 20q13 Exhibits High Level Expression in Prostate

    Linda L. Xu;Naga Shanmugam;Takehiko Segawa;Isabell A. Sesterhenn

  • ANX7, a candidate tumor suppressor gene for prostate cancer

    Meera Srivastava;Lukas Bubendorf;Vasantha Srikantan;Linda Fossom

  • Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer

    Lionel L. Bañez;Premkala Prasanna;Leon Sun;Amina Ali

  • Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes.

    Linda L. Xu;Yong Ping Su;Ron Labiche;Takehiko Segawa

  • Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

    Takehiko Segawa;Martin E Nau;Linda L Xu;Rao N Chilukuri

  • Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.

    Caroline Craig;Min Kim;Ekta Ohri;Robert Wersto

  • Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.

    D Katayose;J Gudas;H Nguyen;S Srivastava

Frequent Co-Authors

David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Isabell A. Sesterhenn
Isabell A. Sesterhenn United States Army Research Laboratory
Judd W. Moul
Judd W. Moul Duke University
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital
Matthew L. Freedman
Matthew L. Freedman Harvard University
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Karin D. Rodland
Karin D. Rodland Pacific Northwest National Laboratory
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center
James L. Mohler
James L. Mohler Roswell Park Cancer Institute
Robin J. Leach
Robin J. Leach The University of Texas Health Science Center at San Antonio

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students with a background in molecular biology often consider expanding their career prospects with online degrees in health and life sciences. If you’re interested in communication sciences, speech pathology bridge programs offer a pathway for non-SLP majors to transition into speech-language pathology, equipping graduates for rewarding roles in healthcare and education.

Nursing is another direction, with programs tailored for those from non-nursing backgrounds. The best online bsn programs for non nurses provide accelerated study options, making it possible to earn a nursing degree efficiently and flexibly. Molecular biology graduates can leverage their scientific knowledge in these programs, enhancing their qualifications in clinical settings.

Career advancement is also possible through the nurse practitioner route. Prospective students often ask how much does a psychiatric nurse practitioner make, as this specialized role offers both high earning potential and meaningful patient care. Wondering how long does it take to be a nurse practitioner? Fast-track programs and online options can help you enter this in-demand career sooner than you might expect.

Best Scientists Citing Shiv Srivastava

Trending Scientists

Recently Published Articles